Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA moves toward easing restrictions on certain peptides BioPharma Dive Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with